Review of the Pathological Results of Appendectomy Specimens

June 1, 2022 updated by: Dr. Mai Kadi, King Abdulaziz University

Histopathological Examination of Cases With Acute Appendicitis, A Retrospective Study at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

This is a retrospective review study to evaluate the histopathological findings post appendectomy

Study Overview

Detailed Description

In this study, 940 cases will be reviewed. Patient demographics, accuracy of imaging modalities, and histopathological findings will be described.

Study Type

Observational

Enrollment (Actual)

940

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jeddah, Saudi Arabia
        • King Abdulaziz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients underwent an appendectomy in king Abdulaziz university hospital in the period between 2010-2017

Description

Inclusion Criteria:

  • Patients underwent an appendectomy in king Abdulaziz university hospital in the period between 2010-2017

Exclusion Criteria:

  • Any other patients will be excluded from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of histopathological findings post appendectomy
Time Frame: 2010-2017
Description of histopathological findings post appendectomy
2010-2017

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relation between disease age, and gender
Time Frame: 2010-2017
Relation between disease age, and gender
2010-2017
Assessment for accuracy of imagining modalities
Time Frame: 2010-2017
Assessment for accuracy of imagining modalities
2010-2017

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mai S Kadi, MBBS, King Abdulaziz University, Jeddah, Saudi Arabia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2021

Primary Completion (ACTUAL)

January 1, 2022

Study Completion (ACTUAL)

February 1, 2022

Study Registration Dates

First Submitted

May 20, 2022

First Submitted That Met QC Criteria

May 20, 2022

First Posted (ACTUAL)

May 25, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 3, 2022

Last Update Submitted That Met QC Criteria

June 1, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe